Ambroxol Terbutaline Guaiphenesin Syrup - ELISABANZ-AT (100 ml)

₹ 110/Bottle

FormSyrup
CompositionCOUGH SYRUP
BrandELISABANZ-AT
Packaging Size100 ml
Packing TypeBottle
PrescriptionYes
ManufacturerARVANTIS PHARMACEUTICALS
Usage/ ApplicationTo alleviate cough and promote mucus clearance in respiratory conditions
Also givesPCD Pharma Franchise
Shelf Life24 months
Country of OriginMade in India
View in Hindi एम्ब्रोक्सोल टर्बुटालिन गुआइफेनेसिन Syrup - ELISABANZ-AT (100 ml)
RATE DISPLAYED ABOVE IS MAXIMUM RETAIL PRICE(MRP) FOR THE SELLING PRICE. PLEASE CONTACT US FOR MORE DETAILS

Exports To: Egypt | Myanmar | Afghanistan | Somalia | Sri Lanka

More Products from Arvantis Pharmaceuticals

Find products similar to Ambroxol Terbutaline Guaiphenesin Syrup - ELISABANZ-AT (100 Ml)

Find related categories

Shipping Information

AvailabilityIn Stock
PriceExcluding all taxes
Ships fromNew Delhi
ShippingAs per delivery location

Product Image

Ambroxol Terbutaline Guaiphenesin Syrup - ELISABANZ-AT (100 ml) image 1Ambroxol Terbutaline Guaiphenesin Syrup - ELISABANZ-AT (100 ml) image 2Ambroxol Terbutaline Guaiphenesin Syrup - ELISABANZ-AT (100 ml) image 3

About the Company

GST Registration Year
2022
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
Mar 2023
GST
07**********2ZY
Import Export Code (IEC)
*******96P
Exports to
Egypt | Myanmar | Afghanistan | Somalia | Sri Lanka

Established in the year 2022, we “Arvantis Pharmaceuticals” are Wholesaler/Distributor of a Medicine. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Gopal Dass Nagpal, whose continual backing and direction have been useful to us for attaining exponential development in the current market.